Researchers have shown that removal of NOS2 gene from an APP transgenic mouse results in development of a much greater spectrum of AD-like pathology and behavioral impairments (Wilcock et al., 2008; Colton et al., 2014). The gene discussed is APP; the disease is Alzheimer disease.